TRV GP IV, LLC — Q2 2024 13F-HR

← TRV GP IV, LLC

Q2 2024 · 13F-HR

TRV GP IV, LLCholdings as filed

Filed 2024-08-09 · accession 0000950123-24-007627

$202.2M

Reported value

Positions

2024-06-30

Period end

View analyzed profile →PRO

Holdings as filed

CUSIP	Ticker	Issuer	Value	% port.	Shares	Class	Voting
87583X109	TNGX	TANGO THERAPEUTICS, INC.	$164.7M	81.5%	19,201,475	Common	SOLE
729139105	PLRX	PLIANT THERAPEUTICS, INC.	$22.9M	11.3%	2,132,867	Common	SOLE
359616109	FULC	FULCRUM THERAPEUTICS, INC.	$14.5M	7.18%	2,343,154	Common	SOLE

Source: SEC EDGAR · raw 13F holdings as filed. The Class column shows the option type when reported (Put/Call) or Common when the issuer's equity is held directly. 13F discloses long positions only.